Agenus, Inc. (AGEN)
3.16
+0.01
(+0.32%)
USD |
NASDAQ |
May 21, 16:00
3.08
-0.08
(-2.53%)
After-Hours: 19:59
Agenus Research and Development Expense (TTM) : 69.64M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 50.82M |
| Amarin Corp. Plc | 16.24M |
| Vertex Pharmaceuticals, Inc. | 3.891B |
| Halozyme Therapeutics, Inc. | 92.25M |
| Protalix Biotherapeutics, Inc. | 21.52M |